- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Dydrogesterone.
Displaying page 1 of 1.
EudraCT Number: 2018-000105-23 | Sponsor Protocol Number: DYDRA001 | Start Date*: 2019-03-01 |
Sponsor Name:UZ Brussel | ||
Full Title: Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: pharmacokinetics and the impact on the endometrium, the microbiota of the genital t... | ||
Medical condition: Female infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003049-37 | Sponsor Protocol Number: CS-10459 | Start Date*: 2022-11-23 |
Sponsor Name:UZ Brussel | ||
Full Title: Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial | ||
Medical condition: Volutary women who wish to donate their oocytes | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004729-34 | Sponsor Protocol Number: NOV-FR04 | Start Date*: 2019-05-21 |
Sponsor Name:Medical Center- UniverstÃty of Freiburg Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics | ||
Full Title: Effects of transdermal estrogen on Bone Mass in adolescent female patients with Anorexia nervosa (AN) – a placebo-controlled, double-blind, randomized, interventional study | ||
Medical condition: Anorexia nervosa | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004491-17 | Sponsor Protocol Number: REMODEL | Start Date*: 2021-03-31 |
Sponsor Name:UZ Brussel | ||
Full Title: Dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles. | ||
Medical condition: progesterone as luteal phase supplementation in frozen embryo transfer cycles | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002993-29 | Sponsor Protocol Number: M13-625 | Start Date*: 2015-07-15 | |||||||||||
Sponsor Name:Abbott Laboratories GmbH | |||||||||||||
Full Title: A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Crinone 8% intravaginal progesterone gel 90 mg daily ... | |||||||||||||
Medical condition: Treatment for the luteal support in in-vitro fertilization (IVF). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002215-26 | Sponsor Protocol Number: M13-563 | Start Date*: 2013-07-18 | |||||||||||
Sponsor Name:Abbott Laboratories GmbH | |||||||||||||
Full Title: A Double-Blind, Double-Dummy, Randomized, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Intravaginal Micronized Progesterone C... | |||||||||||||
Medical condition: Female infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) AT (Completed) ES (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005129-10 | Sponsor Protocol Number: Elovaara09112014 | Start Date*: 2015-01-27 | ||||||||||||||||
Sponsor Name:Irina Elovaara | ||||||||||||||||||
Full Title: Multiple Sclerosis and Menopause: the effect of hormone replacement therapy on clinical picture and immunology of multiple sclerosis | ||||||||||||||||||
Medical condition: Multiple sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004018-44 | Sponsor Protocol Number: MIT-Do0001-C201 | Start Date*: 2016-04-08 | |||||||||||
Sponsor Name:Donesta Bioscience BV | |||||||||||||
Full Title: A Multicentre Dose-Finding, Randomised, Double-Blind, Placebo-Controlled Study to Select the Daily Oral Dose of Estetrol (E4) for the Treatment of Vasomotor Symptoms in Post-Menopausal Women. | |||||||||||||
Medical condition: Vasomotor Symptoms in Post-Menopausal Women | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) PL (Completed) GB (Completed) CZ (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.